Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2012 | 09:20pm CEST

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALERE INC
03/28 ALERE : Receives CLIA Waiver for RSV Test
03/22 ALERE : Medical Laboratories Stocks Under Scanner -- Organovo, DexCom, Quest Dia..
03/21 ALERE INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule ..
03/21 ALERE INC. : Receives NYSE Notice Regarding Late Form 10-K Filing
03/20 ALERE INC. : Declares Cash Dividend on its Series B Convertible Perpetual Prefer..
03/16 ALERE : Receives FDA CLIA Waiver for Alere i RSV Rapid Molecular Test
03/15 ALERE INC. : Other Events (form 8-K)
03/10 ALERE : Provides Update on Arriva Medical
03/07 ALERE : Receives FDA CLIA Waiver for Alere™ i RSV Rapid Molecular Test
03/07 ALERE : Receives FDA CLIA Waiver for Alere(TM) i RSV Rapid Molecular Test
More news
Sector news : Advanced Medical Equipment & Technology - NEC
03/28DJPHILIPS : to Buy Australian pharmacy Sleep Services Firm
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
03/24 Alere up 3% as investors anticipate improved prospects for favorable outcome ..
03/20 After Hours Gainers / Losers
03/15 Alere unable to file 2016 annual report by extended filing date
03/10 Apple Goes Hollywood
03/10 Alere's appeal of CMS's termination of Medicare billing status continues afte..